1. Home
  2. UMH vs NVAX Comparison

UMH vs NVAX Comparison

Compare UMH & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMH
  • NVAX
  • Stock Information
  • Founded
  • UMH 1968
  • NVAX 1987
  • Country
  • UMH United States
  • NVAX United States
  • Employees
  • UMH N/A
  • NVAX N/A
  • Industry
  • UMH Real Estate Investment Trusts
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UMH Real Estate
  • NVAX Health Care
  • Exchange
  • UMH Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • UMH 1.3B
  • NVAX 1.3B
  • IPO Year
  • UMH N/A
  • NVAX 1995
  • Fundamental
  • Price
  • UMH $14.08
  • NVAX $9.23
  • Analyst Decision
  • UMH Buy
  • NVAX Buy
  • Analyst Count
  • UMH 2
  • NVAX 7
  • Target Price
  • UMH $17.75
  • NVAX $14.29
  • AVG Volume (30 Days)
  • UMH 747.5K
  • NVAX 4.4M
  • Earning Date
  • UMH 11-03-2025
  • NVAX 11-11-2025
  • Dividend Yield
  • UMH 6.37%
  • NVAX N/A
  • EPS Growth
  • UMH N/A
  • NVAX N/A
  • EPS
  • UMH 0.13
  • NVAX 2.54
  • Revenue
  • UMH $250,046,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • UMH $6.77
  • NVAX $60.81
  • Revenue Next Year
  • UMH $5.32
  • NVAX N/A
  • P/E Ratio
  • UMH $110.51
  • NVAX $3.62
  • Revenue Growth
  • UMH 8.49
  • NVAX 9.22
  • 52 Week Low
  • UMH $14.09
  • NVAX $5.01
  • 52 Week High
  • UMH $20.42
  • NVAX $13.77
  • Technical
  • Relative Strength Index (RSI)
  • UMH 27.26
  • NVAX 60.85
  • Support Level
  • UMH $14.39
  • NVAX $8.32
  • Resistance Level
  • UMH $14.79
  • NVAX $9.05
  • Average True Range (ATR)
  • UMH 0.29
  • NVAX 0.41
  • MACD
  • UMH -0.04
  • NVAX 0.06
  • Stochastic Oscillator
  • UMH 0.39
  • NVAX 68.06

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: